{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:47:27Z","timestamp":1784288847592,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejphar.2025.178382","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:10:08Z","timestamp":1763640608000},"page":"178382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Targeting the powerhouse: A critical review of mitochondrial inhibitors as a therapeutic strategy in lung cancer"],"prefix":"10.1016","volume":"1008","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4341-5188","authenticated-orcid":false,"given":"Woo Hyun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejphar.2025.178382_bib1","doi-asserted-by":"crossref","DOI":"10.1172\/JCI133081","article-title":"Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas","volume":"131","author":"Amoedo","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178382_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12943-024-02061-4","article-title":"Loss of the tumour suppressor LKB1\/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy","volume":"23","author":"Angelopoulou","year":"2024","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.ejphar.2025.178382_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10565-016-9347-8","article-title":"Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation","volume":"32","author":"Bao","year":"2016","journal-title":"Cell Biol. Toxicol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178382_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ccr.2006.10.020","article-title":"A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth","volume":"11","author":"Bonnet","year":"2007","journal-title":"Cancer Cell"},{"issue":"14","key":"10.1016\/j.ejphar.2025.178382_bib5","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.7150\/ijbs.102424","article-title":"Targeting mitochondria by lipid-selenium conjugate drug results in malate\/fumarate exhaustion and induces mitophagy-mediated necroptosis suppression","volume":"20","author":"Chang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2025.178382_bib6","first-page":"311","article-title":"Zishen huoxue decoction (ZSHX) alleviates ischemic myocardial injury (MI) via Sirt5-\u03b2-tubulin mediated synergistic mechanism of \"mitophagy-unfolded protein response\" and mitophagy","volume":"23","author":"Chang","year":"2025","journal-title":"Chin. J. Nat. Med."},{"issue":"8","key":"10.1016\/j.ejphar.2025.178382_bib7","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1002\/ptr.70008","article-title":"Potential candidates of natural antioxidants from herbs for treating lung disorders: focus on redox balance and natural products","volume":"39","author":"Chang","year":"2025","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2025.178382_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103686","article-title":"Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer","volume":"84","author":"Chen","year":"2025","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.178382_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3892\/or.2022.8266","article-title":"Advances in metformin-based metabolic therapy for non-small cell lung cancer","volume":"47","author":"Chen","year":"2022","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.ejphar.2025.178382_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt1241","article-title":"Lipoylation inhibition enhances radiation control of lung cancer by suppressing homologous recombination DNA damage repair","volume":"11","author":"Chiang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2025.178382_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.freeradbiomed.2019.03.009","article-title":"Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1\u03b1 in NSCLC which can be overcome by OXPHOS inhibition","volume":"135","author":"Cruz-Berm\u00fadez","year":"2019","journal-title":"Free Radical Biol. Med."},{"issue":"16","key":"10.1016\/j.ejphar.2025.178382_bib12","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.3390\/molecules27165207","article-title":"Anti-cancer effects of auranofin in human lung cancer cells by increasing intracellular ROS levels and depleting GSH levels","volume":"27","author":"Cui","year":"2022","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.ejphar.2025.178382_bib13","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41416-020-0778-x","article-title":"Mitochondrial division inhibitor (mdivi-1) decreases oxidative metabolism in cancer","volume":"122","author":"Dai","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.ejphar.2025.178382_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10637-017-0444-1","article-title":"Phase Ib study of the mitochondrial inhibitor ME-344 plus topotecan in patients with previously treated, locally advanced or metastatic small cell lung, ovarian and cervical cancers","volume":"35","author":"Diamond","year":"2017","journal-title":"Invest. N. Drugs"},{"issue":"9","key":"10.1016\/j.ejphar.2025.178382_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18353","article-title":"QiDongNing induces lung cancer cell apoptosis via triggering P53\/DRP1-mediated mitochondrial fission","volume":"28","author":"Ding","year":"2024","journal-title":"J. Cell Mol. Med."},{"issue":"7","key":"10.1016\/j.ejphar.2025.178382_bib16","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s41418-018-0101-z","article-title":"The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer","volume":"25","author":"Fernandez","year":"2018","journal-title":"Cell Death Differ."},{"issue":"7","key":"10.1016\/j.ejphar.2025.178382_bib17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1200\/JCO.2010.31.6208","article-title":"Phase I study of navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors","volume":"29","author":"Gandhi","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ejphar.2025.178382_bib18","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41556-024-01429-4","article-title":"Mitochondria and cell death","volume":"26","author":"Glover","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.ejphar.2025.178382_bib19","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/1759-7714.13925","article-title":"Quercetin induces pro-apoptotic autophagy via SIRT1\/AMPK signaling pathway in human lung cancer cell lines A549 and H1299 in vitro","volume":"12","author":"Guo","year":"2021","journal-title":"Thorac. Cancer"},{"issue":"9","key":"10.1016\/j.ejphar.2025.178382_bib20","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1021\/acs.jmedchem.2c01844","article-title":"Discovery of a potent and oral available complex I OXPHOS inhibitor that abrogates tumor growth and circumvents MEKi resistance","volume":"66","author":"He","year":"2023","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.ejphar.2025.178382_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139933","article-title":"Petasin potently inhibits mitochondrial complex I-based metabolism that supports tumor growth and metastasis","volume":"131","author":"Heishima","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"8049","key":"10.1016\/j.ejphar.2025.178382_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","article-title":"Immune evasion through mitochondrial transfer in the tumour microenvironment","volume":"638","author":"Ikeda","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178382_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms16078","article-title":"Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy","volume":"8","author":"Inoue-Yamauchi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.178382_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154601","article-title":"Andrographolide promoted ferroptosis to repress the development of non-small cell lung cancer through activation of the mitochondrial dysfunction","volume":"109","author":"Jiaqi","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2025.178382_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5428364","article-title":"Enhanced sensitivity of nonsmall cell lung cancer with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors to phenformin: the roles of a metabolic shift to oxidative phosphorylation and redox balance","volume":"2021","author":"Kim","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"21","key":"10.1016\/j.ejphar.2025.178382_bib26","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.2025.0560","article-title":"Small cell lung cancer: a review","volume":"333","author":"Kim","year":"2025","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ejphar.2025.178382_bib27","first-page":"2245","article-title":"Apurinic endonuclease 1 promotes the cisplatin resistance of lung cancer cells by inducing Parkin-mediated mitophagy","volume":"42","author":"Li","year":"2019","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.ejphar.2025.178382_bib28","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41591-018-0019-5","article-title":"Mutations in the SWI\/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer","volume":"24","author":"Lissanu Deribe","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2025.178382_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153370","article-title":"Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2\/HO-1 axis in EGFR wild-type non-small-cell lung cancer","volume":"80","author":"Lou","year":"2021","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.ejphar.2025.178382_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164244","article-title":"A phase II clinical trial of CPI-613 in patients with relapsed or refractory small cell lung carcinoma","volume":"11","author":"Lycan","year":"2016","journal-title":"PLoS One"},{"issue":"52","key":"10.1016\/j.ejphar.2025.178382_bib31","doi-asserted-by":"crossref","first-page":"86313","DOI":"10.18632\/oncotarget.13388","article-title":"Inhibition of oxidative phosphorylation suppresses the development of osimertinib resistance in a preclinical model of EGFR-driven lung adenocarcinoma","volume":"7","author":"Martin","year":"2016","journal-title":"Oncotarget"},{"issue":"10454","key":"10.1016\/j.ejphar.2025.178382_bib32","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","article-title":"New promises and challenges in the treatment of advanced non-small-cell lung cancer","volume":"404","author":"Meyer","year":"2024","journal-title":"Lancet"},{"issue":"7782","key":"10.1016\/j.ejphar.2025.178382_bib33","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41586-019-1715-0","article-title":"In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer","volume":"575","author":"Momcilovic","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178382_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1422686","article-title":"Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality","volume":"15","author":"Pang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2025.178382_bib35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10456-024-09938-4","article-title":"Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction","volume":"27","author":"Pang","year":"2024","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ejphar.2025.178382_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111805","article-title":"Antimycin A: from mitochondrial poison to multifaceted biological probe and therapeutic agent","volume":"422","author":"Park","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.ejphar.2025.178382_bib37","article-title":"The mitochondrial nexus: targeting metabolic vulnerabilities, oxidative stress, and immunomodulation to induce cancer cell death","volume":"1880","author":"Park","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.ejphar.2025.178382_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156982","article-title":"Tanshinone IIA modulates Sirt5 and Metll3 interaction to govern mitochondria-endoplasmic reticulum unfolded protein response in coronary microvascular injury","volume":"145","author":"Pu","year":"2025","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.ejphar.2025.178382_bib39","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s43018-025-00992-5","article-title":"The current and emerging immunotherapy paradigm in small-cell lung cancer","volume":"6","author":"Qin","year":"2025","journal-title":"Nat. Cancer"},{"issue":"7","key":"10.1016\/j.ejphar.2025.178382_bib40","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41401-024-01233-8","article-title":"Clobetasol propionate, a Nrf-2 inhibitor, sensitizes human lung cancer cells to radiation-induced killing via mitochondrial ROS-dependent ferroptosis","volume":"45","author":"Rai","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178382_bib41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41418-022-01064-2","article-title":"Transient targeting of BIM-dependent adaptive MCL1 preservation enhances tumor response to molecular therapeutics in non-small cell lung cancer","volume":"30","author":"Shi","year":"2023","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.ejphar.2025.178382_bib42","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1158\/1078-0432.CCR-20-4128","article-title":"Mitochondrial inhibitor atovaquone increases tumor oxygenation and inhibits hypoxic gene expression in patients with non-small cell lung cancer","volume":"27","author":"Skwarski","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178382_bib43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13046-023-02638-9","article-title":"METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy","volume":"42","author":"Sun","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.ejphar.2025.178382_bib44","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/1759-7714.13904","article-title":"Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy","volume":"12","author":"Tang","year":"2021","journal-title":"Thorac. Cancer"},{"issue":"6","key":"10.1016\/j.ejphar.2025.178382_bib45","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/s43018-025-00996-1","article-title":"Advancing therapeutics in small-cell lung cancer","volume":"6","author":"Thomas","year":"2025","journal-title":"Nat. Cancer"},{"issue":"3","key":"10.1016\/j.ejphar.2025.178382_bib46","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1016\/j.cllc.2018.12.011","article-title":"Exploiting FAsting-mimicking diet and MEtformin to improve the efficacy of platinum-pemetrexed chemotherapy in advanced LKB1-inactivated lung adenocarcinoma: the FAME trial","volume":"20","author":"Vernieri","year":"2019","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.ejphar.2025.178382_bib47","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jare.2024.10.030","article-title":"Astragaloside IV alleviates septic myocardial injury through DUSP1-Prohibitin 2 mediated mitochondrial quality control and ER-autophagy","volume":"75","author":"Wang","year":"2025","journal-title":"J. Adv. Res."},{"issue":"11","key":"10.1016\/j.ejphar.2025.178382_bib48","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.7150\/ijbs.95853","article-title":"Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia\/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy","volume":"20","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178382_bib49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12951-025-03420-z","article-title":"Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance","volume":"23","author":"Wang","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejphar.2025.178382_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108539","article-title":"Luteolin enhances TRAIL sensitivity in non-small cell lung cancer cells through increasing DR5 expression and Drp1-mediated mitochondrial fission","volume":"692","author":"Wu","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178382_bib51","doi-asserted-by":"crossref","first-page":"610","DOI":"10.18632\/oncotarget.6311","article-title":"Inhibition of mitochondrial glutaminase activity reverses acquired erlotinib resistance in non-small cell lung cancer","volume":"7","author":"Xie","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2025.178382_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217075","article-title":"Novel SERCA2 inhibitor diphyllin displays anti-tumor effect in non-small cell lung cancer by promoting endoplasmic reticulum stress and mitochondrial dysfunction","volume":"598","author":"Xu","year":"2024","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.ejphar.2025.178382_bib53","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7150\/ijbs.65019","article-title":"Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer","volume":"18","author":"Yan","year":"2022","journal-title":"Int. J. Biol. Sci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T17:24:46Z","timestamp":1765560286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925011367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":53,"alternative-id":["S0014299925011367"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178382","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the powerhouse: A critical review of mitochondrial inhibitors as a therapeutic strategy in lung cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178382","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178382"}}